Delivery Order SPE2DB20D3101-SPE2DB25FRHG5
Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $27,989.79 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on December 3, 2025, with completion scheduled for December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $46,987.66 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count packages) on November 28, 2025, with completion scheduled for December 1, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $12,163.66 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 17, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in the federal pharmaceutical...
- The Defense Logistics Agency awarded a $2,053.56 delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,332.48 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on September 11, 2025, with completion scheduled for September 12, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,007.34 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed price contract. This non-competitive delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order valued at $41,547.36 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on October 27, 2025, with completion targeted for October 28, 2025. This firm fixed-price, non-set-aside contract represents a single delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count units) valued at $5,359.48 on November 17, 2025, with completion scheduled for November 18, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's critical pharmaceutical supply role within the federal medical procurement system. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $6,564.66 to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg on October 22, 2025, with completion scheduled for October 23, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitive award under the company's broader pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $35,933.54 delivery order to AmerisourceBergen Drug Corp for Xifaxan 550 mg tablets (60-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and...